Product Information
ALLOPURINOL 100 MG TABLET is a generic product labeled by Rising Pharma Holdings Inc., priced at $0.0317 per EA under NDC 16571088309. Its NADAC has been published 94 times since Nov 6, 2024.
FDA first approved this application before 1982. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
The High Outlier badge above means this manufacturer's average price in the allopurinol market falls above Q3 + 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.
Strength
100 mg/1
Manufacturer
Rising Pharma Holdings Inc.NDC
16571088309
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Effective Date
8/19/2026
Active Ingredients
ALLOPURINOLApproval Type
Authorized Generic (NDA)
FDA Application
NDA016084FDA Approved
Before 1982
TE Code
AB
On Market Since
9/21/2023
Pharmacological Classes
Price Statistics
The NADAC for ALLOPURINOL 100 MG TABLET has been published 94 times since Nov 6, 2024, and over the history we have for it it has declined 33.5%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.0317 per EA |
|---|---|
| All-time high | $0.0477 (Nov 13, 2024) |
| All-time low | $0.0317 (Aug 19, 2026) |
| 52-week high | $0.0414 |
| 52-week low | $0.0317 |
| Median price | $0.0381 |
| Average price | $0.0380 |
| Largest weekly change | -28.6% (Nov 20, 2024) |
| Weeks tracked | 94 |
| Tracking since | Nov 6, 2024 |
Generic Alternatives
The matcher finds 6 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of ALLOPURINOL 100 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for ALLOPURINOL 100 MG TABLET, manufactured by Rising Pharma Holdings Inc., is $0.0317 per EA (NDC 16571088309), effective Aug 19, 2026.
How has the price of ALLOPURINOL 100 MG TABLET changed over time?
Over the history we have for it, the NADAC for ALLOPURINOL 100 MG TABLET has declined 33.5%. It has been tracked across 94 weekly CMS publications since Nov 6, 2024.
What are the highest and lowest recorded NADAC prices for ALLOPURINOL 100 MG TABLET?
Since Nov 6, 2024, the NADAC for ALLOPURINOL 100 MG TABLET has ranged from a low of $0.0317 (Aug 19, 2026) to a high of $0.0477 (Nov 13, 2024), with a median of $0.0381 per EA.
Are there cheaper alternatives to ALLOPURINOL 100 MG TABLET?
6 manufacturers publish a NADAC-priced product with the same active ingredient and strength as ALLOPURINOL 100 MG TABLET in a comparable dosage form, but none are currently priced below it.
Who manufactures ALLOPURINOL 100 MG TABLET?
ALLOPURINOL 100 MG TABLET (NDC 16571088309) is labeled by Rising Pharma Holdings Inc., and CMS classifies it as a generic product.